Category: BioTech

Gilead Sciences GILD NASDAQ:GILD
Analysis, BioTech, Diversified Tech, Finance, Mergers & Acquisitions, Semiconductors, Services Sector, software, Software, Tech IPO

White Mountains’ Underwriting Margins Drive 1Q Book Value Increase

A benign catastrophe season and continued improvement in underwriting margins at majority-owned OneBeacon OB led to a 3% sequential increase in adjusted book value to $606 per share at White Mountains Insurance Group WTM . In comparison with last year’s first quarter, the combined ratio (expense divided by earned premiums) fell to 81% from 84% at Sirius Group, White Mountains’ reinsurance subsidiary, while OneBeacon also … Continue reading White Mountains’ Underwriting Margins Drive 1Q Book Value Increase

John MeadyLeave a comment
BioTech, Finance

Active Biotech Stock: A Look at Mannkind Corp

Shares of MannKind Corp. have been on a wild ride over the past year. Most of this volatility is the result of emotionally-charged retail investors pushing the stock past realistic valuation levels. This stock serves as another glaring example as to why it’s generally a bad idea to follow the crowd when investing in biotech stocks. MannKind Corp. (NASDAQ MNKD) is the latest cult biotech … Continue reading Active Biotech Stock: A Look at Mannkind Corp

Richard Atkins
FB Nasdaq FB Facebook
Analysis, BioTech, Diversified Tech, Finance, Mergers & Acquisitions, Semiconductors, Services Sector, Software, software, Tech IPO

Growing Competition on the Cotai Strip Leads to a Bad Quarterly Hand for Wynn Resorts

Wynn Resorts WYNN reported weak first-quarter results, as the company continued to perform poorly in Macau due to intensifying competition from new casinos on the Cotai Strip. Revenue and EBITDA were above consensus estimates, but only because the company had an unusually high hold rate for VIP table games in Macau and table games in Las Vegas. Revenue increased 5% to $1.38 billion (compared to … Continue reading Growing Competition on the Cotai Strip Leads to a Bad Quarterly Hand for Wynn Resorts

John MeadyLeave a comment
Gilead Sciences GILD NASDAQ:GILD
Analysis, BioTech, Commodities, Diversified Tech, Finance, Global Equity, Mergers & Acquisitions, Semiconductors, Services Sector, Software, software, Tech IPO

Strong Lumber and Panel Prices Buoy Weyerhaeuser’s 1Q; Deferred Harvests Causing Log Prices to Lag

Positive momentum in the long-suffering wood products business led improved results in Weyerhaeuser’s WY first quarter, as the segment benefited from improved housing demand and a cautious lumber industry that hasn’t fully recalibrated supply to meet the new demand reality. Results were more tepid in Weyerhaeuser’s other segments, as log prices haven’t enjoyed the kind of surge we’ve seen in lumber and panel prices, homebuilding … Continue reading Strong Lumber and Panel Prices Buoy Weyerhaeuser’s 1Q; Deferred Harvests Causing Log Prices to Lag

John MeadyLeave a comment
BioTech, Finance

Biotech Stocks Are A Bargain in Today’s Market

Bargain hunters should focus on biotechs since momentum is clearly on their side. On Wednesday, stocks closed higher, led by the small- and mid-cap sectors. The Nasdaq led all other indices, up 1%, while the S&P 500 rose 0.7% with 7 of 10 sectors advancing, and the Dow industrials gained 0.6%. Retail sales for July were flat, but rather than this being interpreted as a … Continue reading Biotech Stocks Are A Bargain in Today’s Market

Richard Atkins
BioTech, Finance

Biotech News: Allscripts Healthcare & Clinical Architecture Extend Critical Alliance

Extending its association with Carmel, IN-based software solutions provider – Clinical Architecture, Allscripts Healthcare Solutions, Inc. (MDRX) contracted to integrate the former’s comprehensive terminology management system, Symedical, with its dbMotion interoperability platform to streamline vocabulary mapping. By incorporating Symedical, Allscripts intends to provide its clients with efficient and enhanced mapping tools and improved vocabulary distribution. This would allow the clients to achieve health information exchange … Continue reading Biotech News: Allscripts Healthcare & Clinical Architecture Extend Critical Alliance

Richard Atkins